bexarotene has been researched along with prednisone in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Csuk, R; Hoenke, S; Serbian, I | 1 |
| Beyeler, M; Dummer, R | 1 |
| Bohmeyer, J; Gellrich, S; Kremer, A; Luger, T; Muche, M; Nashan, D; Stadler, R; Sterry, W | 1 |
| Acebo, E; Díaz-Pérez, JL; García-Ruiz, JC; Izu, R; Martínez de Lagrán, Z; Pérez-Barrio, S | 1 |
| Catherwood, M; Morris, TC; Pettengell, R; Sheehy, O | 1 |
| Hall, AG; Marshall, GD; Morris, AE | 1 |
| Chen, PL; Malachowski, SJ; Seminario-Vidal, L; Sun, J | 1 |
| Briones, J; Espeso, M; Martín, A; Mozos, A; Novelli, S; Sánchez, JJ | 1 |
4 review(s) available for bexarotene and prednisone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Standard and experimental therapy of cutaneous T-cell lymphoma].
Topics: Adrenal Cortex Hormones; Aminoquinolines; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Humans; Imiquimod; Interferon alpha-2; Interferon-alpha; Lymphoma, T-Cell; Methotrexate; Photopheresis; Prednisone; PUVA Therapy; Radioisotope Teletherapy; Radiotherapy Dosage; Radiotherapy, High-Energy; Recombinant Proteins; Retinoids; Skin Neoplasms; Tetrahydronaphthalenes; Vincristine | 2003 |
Not all that itches is urticaria.
Topics: Anti-Inflammatory Agents; Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Bexarotene; Biopsy, Needle; Black or African American; Diagnosis, Differential; Education, Medical, Continuing; Eosinophilia; Female; Humans; Ki-1 Antigen; Methotrexate; Middle Aged; Mycosis Fungoides; Prednisone; Pruritus; Skin Neoplasms; Tetrahydronaphthalenes; Urticaria | 2012 |
Diagnosis and Management of Cutaneous B-Cell Lymphomas.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Borrelia burgdorferi; Cyclophosphamide; Cytoreduction Surgical Procedures; Dermatologic Surgical Procedures; Disease Management; Doxorubicin; Humans; Injections, Intralesional; Lyme Disease; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Polyethylene Glycols; Prednisone; Rituximab; Skin Neoplasms; Vincristine | 2019 |
5 other study(ies) available for bexarotene and prednisone
| Article | Year |
|---|---|
Synthesis of some steroidal mitocans of nanomolar cytotoxicity acting by apoptosis.
Topics: Androstenes; Antineoplastic Agents; Apoptosis; Bexarotene; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholesterol; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Mitochondria; Molecular Structure; Prednisone; Rhodamines; Structure-Activity Relationship; Testosterone | 2020 |
Bexarotene--an alternative therapy for progressive cutaneous T-cell lymphoma? First experiences.
Topics: Adult; Aged; Aminoquinolines; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Female; Humans; Imiquimod; Immunosuppressive Agents; Interferons; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Prednisone; PUVA Therapy; Remission Induction; Skin; Skin Neoplasms; Tacrolimus; Tetrahydronaphthalenes; Time Factors; Treatment Outcome; Vincristine | 2003 |
[Autologous hematopoietic stem cell transplantation followed by oral bexarotene in a patient with advanced mycosis fungoides].
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Busulfan; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Interferon alpha-2; Interferon-alpha; Mechlorethamine; Methylprednisolone; Mycosis Fungoides; Peripheral Blood Stem Cell Transplantation; Prednisone; PUVA Therapy; Recombinant Proteins; Remission Induction; Tetrahydronaphthalenes; Transplantation, Autologous; Vincristine | 2008 |
Sustained response of primary cutaneous CD30 positive anaplastic large cell lymphoma to bexarotene and photopheresis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Facial Neoplasms; Female; Humans; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Neoplasm Recurrence, Local; Photopheresis; Prednisone; Salvage Therapy; Skin Neoplasms; Tetrahydronaphthalenes; Vincristine | 2009 |
Management experience of advanced-stage mycosis fungoides/Sézary syndrome: a retrospective study from Spanish haematology referral units.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Cyclophosphamide; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Palliative Care; Prednisone; Referral and Consultation; Retrospective Studies; Sezary Syndrome; Skin Neoplasms; Spain; Survival Analysis; Transplantation, Homologous; Vincristine | 2020 |